Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 Sep 1;334(Pt 2):297–314. doi: 10.1042/bj3340297

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

P C Heinrich 1, I Behrmann 1, G Müller-Newen 1, F Schaper 1, L Graeve 1
PMCID: PMC1219691  PMID: 9716487

Abstract

The family of cytokines signalling through the common receptor subunit gp130 comprises interleukin (IL)-6, IL-11, leukaemia inhibitory factor, oncostatin M, ciliary neurotrophic factor and cardiotrophin-1. These so-called IL-6-type cytokines play an important role in the regulation of complex cellular processes such as gene activation, proliferation and differentiation. The current knowledge on the signal-transduction mechanisms of these cytokines from the plasma membrane to the nucleus is reviewed. In particular, we focus on the assembly of receptor complexes after ligand binding, the activation of receptor-associated kinases of the Janus family, and the recruitment and phosphorylation of transcription factors of the STAT family, which dimerize, translocate to the nucleus, and bind to enhancer elements of respective target genes leading to transcriptional activation. The important players in the signalling pathway, namely the cytokines and the receptor components, the Janus kinases Jak1, Jak2 and Tyk2, the signal transducers and activators of transcription STAT1 and STAT3 and the tyrosine phosphatase SHP2 [SH2 (Src homology 2) domain-containing tyrosine phosphatase] are introduced and their structural/functional properties are discussed. Furthermore, we review various mechanisms involved in the termination of the IL-6-type cytokine signalling, namely the action of tyrosine phosphatases, proteasome, Jak kinase inhibitors SOCS (suppressor of cytokine signalling), protein inhibitors of activated STATs (PIAS), and internalization of the cytokine receptors via gp130. Although all IL-6-type cytokines signal through the gp130/Jak/STAT pathway, the comparison of their physiological properties shows that they elicit not only similar, but also distinct, biological responses. This is reflected in the different phenotypes of IL-6-type-cytokine knock-out animals.

Full Text

The Full Text of this article is available as a PDF (676.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad S., Banville D., Zhao Z., Fischer E. H., Shen S. H. A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2197–2201. doi: 10.1073/pnas.90.6.2197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baumann H., Symes A. J., Comeau M. R., Morella K. K., Wang Y., Friend D., Ziegler S. F., Fink J. S., Gearing D. P. Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol Cell Biol. 1994 Jan;14(1):138–146. doi: 10.1128/mcb.14.1.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990 Sep;87(18):6934–6938. doi: 10.1073/pnas.87.18.6934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Becker S., Groner B., Müller C. W. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature. 1998 Jul 9;394(6689):145–151. doi: 10.1038/28101. [DOI] [PubMed] [Google Scholar]
  5. Behrmann I., Janzen C., Gerhartz C., Schmitz-Van de Leur H., Hermanns H., Heesel B., Graeve L., Horn F., Tavernier J., Heinrich P. C. A single STAT recruitment module in a chimeric cytokine receptor complex is sufficient for STAT activation. J Biol Chem. 1997 Feb 21;272(8):5269–5274. doi: 10.1074/jbc.272.8.5269. [DOI] [PubMed] [Google Scholar]
  6. Bennett A. M., Hausdorff S. F., O'Reilly A. M., Freeman R. M., Neel B. G. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol Cell Biol. 1996 Mar;16(3):1189–1202. doi: 10.1128/mcb.16.3.1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Berger L. C., Hawley R. G. Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells. Blood. 1997 Jan 1;89(1):261–271. [PubMed] [Google Scholar]
  8. Bhat G. J., Thekkumkara T. J., Thomas W. G., Conrad K. M., Baker K. M. Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein. J Biol Chem. 1994 Dec 16;269(50):31443–31449. [PubMed] [Google Scholar]
  9. Briscoe J., Guschin D., Müller M. Signal transduction. Just another signalling pathway. Curr Biol. 1994 Nov 1;4(11):1033–1035. doi: 10.1016/s0960-9822(00)00236-0. [DOI] [PubMed] [Google Scholar]
  10. Brown R. T., Ades I. Z., Nordan R. P. An acute phase response factor/NF-kappa B site downstream of the junB gene that mediates responsiveness to interleukin-6 in a murine plasmacytoma. J Biol Chem. 1995 Dec 29;270(52):31129–31135. doi: 10.1074/jbc.270.52.31129. [DOI] [PubMed] [Google Scholar]
  11. Bugno M., Graeve L., Gatsios P., Koj A., Heinrich P. C., Travis J., Kordula T. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res. 1995 Dec 25;23(24):5041–5047. doi: 10.1093/nar/23.24.5041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Caldenhoven E., van Dijk T. B., Solari R., Armstrong J., Raaijmakers J. A., Lammers J. W., Koenderman L., de Groot R. P. STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem. 1996 May 31;271(22):13221–13227. doi: 10.1074/jbc.271.22.13221. [DOI] [PubMed] [Google Scholar]
  13. Case R. D., Piccione E., Wolf G., Benett A. M., Lechleider R. J., Neel B. G., Shoelson S. E. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides. J Biol Chem. 1994 Apr 8;269(14):10467–10474. [PubMed] [Google Scholar]
  14. Castell J. V., Geiger T., Gross V., Andus T., Walter E., Hirano T., Kishimoto T., Heinrich P. C. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem. 1988 Nov 1;177(2):357–361. doi: 10.1111/j.1432-1033.1988.tb14384.x. [DOI] [PubMed] [Google Scholar]
  15. Castell J., Klapproth J., Gross V., Walter E., Andus T., Snyers L., Content J., Heinrich P. C. Fate of interleukin-6 in the rat. Involvement of skin in its catabolism. Eur J Biochem. 1990 Apr 20;189(1):113–118. doi: 10.1111/j.1432-1033.1990.tb15466.x. [DOI] [PubMed] [Google Scholar]
  16. Ceresa B. P., Pessin J. E. Insulin stimulates the serine phosphorylation of the signal transducer and activator of transcription (STAT3) isoform. J Biol Chem. 1996 May 24;271(21):12121–12124. doi: 10.1074/jbc.271.21.12121. [DOI] [PubMed] [Google Scholar]
  17. Chen M., Cheng A., Chen Y. Q., Hymel A., Hanson E. P., Kimmel L., Minami Y., Taniguchi T., Changelian P. S., O'Shea J. J. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6910–6915. doi: 10.1073/pnas.94.13.6910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chen X. H., Patel B. K., Wang L. M., Frankel M., Ellmore N., Flavell R. A., LaRochelle W. J., Pierce J. H. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules. J Biol Chem. 1997 Mar 7;272(10):6556–6560. doi: 10.1074/jbc.272.10.6556. [DOI] [PubMed] [Google Scholar]
  19. Chen X., Vinkemeier U., Zhao Y., Jeruzalmi D., Darnell J. E., Jr, Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell. 1998 May 29;93(5):827–839. doi: 10.1016/s0092-8674(00)81443-9. [DOI] [PubMed] [Google Scholar]
  20. Chuang L. M., Wang P. H., Chang H. M., Lee S. C. Novel pathway of insulin signaling involving Stat1alpha in Hep3B cells. Biochem Biophys Res Commun. 1997 Jun 18;235(2):317–320. doi: 10.1006/bbrc.1997.6771. [DOI] [PubMed] [Google Scholar]
  21. Chung C. D., Liao J., Liu B., Rao X., Jay P., Berta P., Shuai K. Specific inhibition of Stat3 signal transduction by PIAS3. Science. 1997 Dec 5;278(5344):1803–1805. doi: 10.1126/science.278.5344.1803. [DOI] [PubMed] [Google Scholar]
  22. Chung J., Uchida E., Grammer T. C., Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol. 1997 Nov;17(11):6508–6516. doi: 10.1128/mcb.17.11.6508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Clackson T., Wells J. A. A hot spot of binding energy in a hormone-receptor interface. Science. 1995 Jan 20;267(5196):383–386. doi: 10.1126/science.7529940. [DOI] [PubMed] [Google Scholar]
  24. Coffer P., Lutticken C., van Puijenbroek A., Klop-de Jonge M., Horn F., Kruijer W. Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction. Oncogene. 1995 Mar 2;10(5):985–994. [PubMed] [Google Scholar]
  25. Curtis R., Adryan K. M., Zhu Y., Harkness P. J., Lindsay R. M., DiStefano P. S. Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury. Nature. 1993 Sep 16;365(6443):253–255. doi: 10.1038/365253a0. [DOI] [PubMed] [Google Scholar]
  26. Dahmen H., Horsten U., Küster A., Jacques Y., Minvielle S., Kerr I. M., Ciliberto G., Paonessa G., Heinrich P. C., Müller-Newen G. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. Biochem J. 1998 May 1;331(Pt 3):695–702. doi: 10.1042/bj3310695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Darnell J. E., Jr, Kerr I. M., Stark G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994 Jun 3;264(5164):1415–1421. doi: 10.1126/science.8197455. [DOI] [PubMed] [Google Scholar]
  28. Davis S., Aldrich T. H., Stahl N., Pan L., Taga T., Kishimoto T., Ip N. Y., Yancopoulos G. D. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science. 1993 Jun 18;260(5115):1805–1808. doi: 10.1126/science.8390097. [DOI] [PubMed] [Google Scholar]
  29. Davis S., Aldrich T. H., Valenzuela D. M., Wong V. V., Furth M. E., Squinto S. P., Yancopoulos G. D. The receptor for ciliary neurotrophic factor. Science. 1991 Jul 5;253(5015):59–63. doi: 10.1126/science.1648265. [DOI] [PubMed] [Google Scholar]
  30. De Serio A., Graziani R., Laufer R., Ciliberto G., Paonessa G. In vitro binding of ciliary neurotrophic factor to its receptors: evidence for the formation of an IL-6-type hexameric complex. J Mol Biol. 1995 Dec 15;254(5):795–800. doi: 10.1006/jmbi.1995.0655. [DOI] [PubMed] [Google Scholar]
  31. DeChiara T. M., Vejsada R., Poueymirou W. T., Acheson A., Suri C., Conover J. C., Friedman B., McClain J., Pan L., Stahl N. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell. 1995 Oct 20;83(2):313–322. doi: 10.1016/0092-8674(95)90172-8. [DOI] [PubMed] [Google Scholar]
  32. Deberry C., Mou S., Linnekin D. Stat1 associates with c-kit and is activated in response to stem cell factor. Biochem J. 1997 Oct 1;327(Pt 1):73–80. doi: 10.1042/bj3270073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Dechert U., Adam M., Harder K. W., Clark-Lewis I., Jirik F. Characterization of protein tyrosine phosphatase SH-PTP2. Study of phosphopeptide substrates and possible regulatory role of SH2 domains. J Biol Chem. 1994 Feb 25;269(8):5602–5611. [PubMed] [Google Scholar]
  34. Diamant M., Rieneck K., Mechti N., Zhang X. G., Svenson M., Bendtzen K., Klein B. Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130. FEBS Lett. 1997 Jul 28;412(2):379–384. doi: 10.1016/s0014-5793(97)00750-3. [DOI] [PubMed] [Google Scholar]
  35. Dittrich E., Haft C. R., Muys L., Heinrich P. C., Graeve L. A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor. J Biol Chem. 1996 Mar 8;271(10):5487–5494. doi: 10.1074/jbc.271.10.5487. [DOI] [PubMed] [Google Scholar]
  36. Dittrich E., Rose-John S., Gerhartz C., Müllberg J., Stoyan T., Yasukawa K., Heinrich P. C., Graeve L. Identification of a region within the cytoplasmic domain of the interleukin-6 (IL-6) signal transducer gp130 important for ligand-induced endocytosis of the IL-6 receptor. J Biol Chem. 1994 Jul 22;269(29):19014–19020. [PubMed] [Google Scholar]
  37. Duhé R. J., Farrar W. L. Characterization of active and inactive forms of the JAK2 protein-tyrosine kinase produced via the baculovirus expression vector system. J Biol Chem. 1995 Sep 29;270(39):23084–23089. doi: 10.1074/jbc.270.39.23084. [DOI] [PubMed] [Google Scholar]
  38. Duhé R. J., Farrar W. L. Structural and mechanistic aspects of Janus kinases: how the two-faced god wields a double-edged sword. J Interferon Cytokine Res. 1998 Jan;18(1):1–15. doi: 10.1089/jir.1998.18.1. [DOI] [PubMed] [Google Scholar]
  39. Endo T. A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 1997 Jun 26;387(6636):921–924. doi: 10.1038/43213. [DOI] [PubMed] [Google Scholar]
  40. Ernst M., Gearing D. P., Dunn A. R. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J. 1994 Apr 1;13(7):1574–1584. doi: 10.1002/j.1460-2075.1994.tb06420.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ernst M., Oates A., Dunn A. R. Gp130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. J Biol Chem. 1996 Nov 22;271(47):30136–30143. doi: 10.1074/jbc.271.47.30136. [DOI] [PubMed] [Google Scholar]
  42. Feng G. S., Hui C. C., Pawson T. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science. 1993 Mar 12;259(5101):1607–1611. doi: 10.1126/science.8096088. [DOI] [PubMed] [Google Scholar]
  43. Feng J., Witthuhn B. A., Matsuda T., Kohlhuber F., Kerr I. M., Ihle J. N. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol Cell Biol. 1997 May;17(5):2497–2501. doi: 10.1128/mcb.17.5.2497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Freeman R. M., Jr, Plutzky J., Neel B. G. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11239–11243. doi: 10.1073/pnas.89.23.11239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Fuhrer D. K., Feng G. S., Yang Y. C. Syp associates with gp130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse preadipocytes. J Biol Chem. 1995 Oct 20;270(42):24826–24830. doi: 10.1074/jbc.270.42.24826. [DOI] [PubMed] [Google Scholar]
  46. Fujio Y., Kunisada K., Hirota H., Yamauchi-Takihara K., Kishimoto T. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J Clin Invest. 1997 Jun 15;99(12):2898–2905. doi: 10.1172/JCI119484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Fujitani Y., Hibi M., Fukada T., Takahashi-Tezuka M., Yoshida H., Yamaguchi T., Sugiyama K., Yamanaka Y., Nakajima K., Hirano T. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT. Oncogene. 1997 Feb 20;14(7):751–761. doi: 10.1038/sj.onc.1200907. [DOI] [PubMed] [Google Scholar]
  48. Fukada T., Hibi M., Yamanaka Y., Takahashi-Tezuka M., Fujitani Y., Yamaguchi T., Nakajima K., Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity. 1996 Nov;5(5):449–460. doi: 10.1016/s1074-7613(00)80501-4. [DOI] [PubMed] [Google Scholar]
  49. Gaillard J. P., Bataille R., Brailly H., Zuber C., Yasukawa K., Attal M., Maruo N., Taga T., Kishimoto T., Klein B. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol. 1993 Apr;23(4):820–824. doi: 10.1002/eji.1830230408. [DOI] [PubMed] [Google Scholar]
  50. Gauzzi M. C., Barbieri G., Richter M. F., Uzé G., Ling L., Fellous M., Pellegrini S. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11839–11844. doi: 10.1073/pnas.94.22.11839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Gauzzi M. C., Velazquez L., McKendry R., Mogensen K. E., Fellous M., Pellegrini S. Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J Biol Chem. 1996 Aug 23;271(34):20494–20500. doi: 10.1074/jbc.271.34.20494. [DOI] [PubMed] [Google Scholar]
  52. Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 1992 Mar 13;255(5050):1434–1437. doi: 10.1126/science.1542794. [DOI] [PubMed] [Google Scholar]
  53. Gearing D. P., Thut C. J., VandeBos T., Gimpel S. D., Delaney P. B., King J., Price V., Cosman D., Beckmann M. P. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 1991 Oct;10(10):2839–2848. doi: 10.1002/j.1460-2075.1991.tb07833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Gerhartz C., Dittrich E., Stoyan T., Rose-John S., Yasukawa K., Heinrich P. C., Graeve L. Biosynthesis and half-life of the interleukin-6 receptor and its signal transducer gp130. Eur J Biochem. 1994 Jul 1;223(1):265–274. doi: 10.1111/j.1432-1033.1994.tb18991.x. [DOI] [PubMed] [Google Scholar]
  55. Gerhartz C., Heesel B., Sasse J., Hemmann U., Landgraf C., Schneider-Mergener J., Horn F., Heinrich P. C., Graeve L. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation. J Biol Chem. 1996 May 31;271(22):12991–12998. doi: 10.1074/jbc.271.22.12991. [DOI] [PubMed] [Google Scholar]
  56. Graeve L., Korolenko T. A., Hemmann U., Weiergräber O., Dittrich E., Heinrich P. C. A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130. FEBS Lett. 1996 Dec 9;399(1-2):131–134. doi: 10.1016/s0014-5793(96)01305-1. [DOI] [PubMed] [Google Scholar]
  57. Greenlund A. C., Farrar M. A., Viviano B. L., Schreiber R. D. Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 1994 Apr 1;13(7):1591–1600. doi: 10.1002/j.1460-2075.1994.tb06422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Greenlund A. C., Morales M. O., Viviano B. L., Yan H., Krolewski J., Schreiber R. D. Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity. 1995 Jun;2(6):677–687. doi: 10.1016/1074-7613(95)90012-8. [DOI] [PubMed] [Google Scholar]
  59. Grötzinger J., Kurapkat G., Wollmer A., Kalai M., Rose-John S. The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes. Proteins. 1997 Jan;27(1):96–109. [PubMed] [Google Scholar]
  60. Guschin D., Rogers N., Briscoe J., Witthuhn B., Watling D., Horn F., Pellegrini S., Yasukawa K., Heinrich P., Stark G. R. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 1995 Apr 3;14(7):1421–1429. doi: 10.1002/j.1460-2075.1995.tb07128.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Görlich D., Mattaj I. W. Nucleocytoplasmic transport. Science. 1996 Mar 15;271(5255):1513–1518. doi: 10.1126/science.271.5255.1513. [DOI] [PubMed] [Google Scholar]
  62. Harroch S., Revel M., Chebath J. Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA. EMBO J. 1994 Apr 15;13(8):1942–1949. doi: 10.1002/j.1460-2075.1994.tb06463.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Haspel R. L., Salditt-Georgieff M., Darnell J. E., Jr The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J. 1996 Nov 15;15(22):6262–6268. [PMC free article] [PubMed] [Google Scholar]
  64. Heaney M. L., Golde D. W. Soluble cytokine receptors. Blood. 1996 Feb 1;87(3):847–857. [PubMed] [Google Scholar]
  65. Heilker R., Manning-Krieg U., Zuber J. F., Spiess M. In vitro binding of clathrin adaptors to sorting signals correlates with endocytosis and basolateral sorting. EMBO J. 1996 Jun 3;15(11):2893–2899. [PMC free article] [PubMed] [Google Scholar]
  66. Heim M. H., Kerr I. M., Stark G. R., Darnell J. E., Jr Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science. 1995 Mar 3;267(5202):1347–1349. doi: 10.1126/science.7871432. [DOI] [PubMed] [Google Scholar]
  67. Hemmann U., Gerhartz C., Heesel B., Sasse J., Kurapkat G., Grötzinger J., Wollmer A., Zhong Z., Darnell J. E., Jr, Graeve L. Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation. J Biol Chem. 1996 May 31;271(22):12999–13007. doi: 10.1074/jbc.271.22.12999. [DOI] [PubMed] [Google Scholar]
  68. Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 1990 Dec 21;63(6):1149–1157. doi: 10.1016/0092-8674(90)90411-7. [DOI] [PubMed] [Google Scholar]
  69. Hill C. S., Treisman R. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J. 1995 Oct 16;14(20):5037–5047. doi: 10.1002/j.1460-2075.1995.tb00186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Hilton D. J., Hilton A. A., Raicevic A., Rakar S., Harrison-Smith M., Gough N. M., Begley C. G., Metcalf D., Nicola N. A., Willson T. A. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 1994 Oct 17;13(20):4765–4775. doi: 10.1002/j.1460-2075.1994.tb06802.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Hilton D. J., Nicola N. A., Metcalf D. Distribution and binding properties of receptors for leukaemia inhibitory factor. Ciba Found Symp. 1992;167:227–244. doi: 10.1002/9780470514269.ch14. [DOI] [PubMed] [Google Scholar]
  72. Hof P., Pluskey S., Dhe-Paganon S., Eck M. J., Shoelson S. E. Crystal structure of the tyrosine phosphatase SHP-2. Cell. 1998 Feb 20;92(4):441–450. doi: 10.1016/s0092-8674(00)80938-1. [DOI] [PubMed] [Google Scholar]
  73. Honda M., Yamamoto S., Cheng M., Yasukawa K., Suzuki H., Saito T., Osugi Y., Tokunaga T., Kishimoto T. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol. 1992 Apr 1;148(7):2175–2180. [PubMed] [Google Scholar]
  74. Horsten U., Müller-Newen G., Gerhartz C., Wollmer A., Wijdenes J., Heinrich P. C., Grötzinger J. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. J Biol Chem. 1997 Sep 19;272(38):23748–23757. doi: 10.1074/jbc.272.38.23748. [DOI] [PubMed] [Google Scholar]
  75. Horsten U., Schmitz-Van de Leur H., Müllberg J., Heinrich P. C., Rose-John S. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor. FEBS Lett. 1995 Feb 20;360(1):43–46. doi: 10.1016/0014-5793(95)00053-c. [DOI] [PubMed] [Google Scholar]
  76. Horvai A. E., Xu L., Korzus E., Brard G., Kalafus D., Mullen T. M., Rose D. W., Rosenfeld M. G., Glass C. K. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1074–1079. doi: 10.1073/pnas.94.4.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Horvath C. M., Stark G. R., Kerr I. M., Darnell J. E., Jr Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex. Mol Cell Biol. 1996 Dec;16(12):6957–6964. doi: 10.1128/mcb.16.12.6957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Horvath C. M., Wen Z., Darnell J. E., Jr A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 1995 Apr 15;9(8):984–994. doi: 10.1101/gad.9.8.984. [DOI] [PubMed] [Google Scholar]
  79. Hou X. S., Melnick M. B., Perrimon N. Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell. 1996 Feb 9;84(3):411–419. doi: 10.1016/s0092-8674(00)81286-6. [DOI] [PubMed] [Google Scholar]
  80. Ichihara M., Hara T., Kim H., Murate T., Miyajima A. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood. 1997 Jul 1;90(1):165–173. [PubMed] [Google Scholar]
  81. Ihle J. N. Cytokine receptor signalling. Nature. 1995 Oct 19;377(6550):591–594. doi: 10.1038/377591a0. [DOI] [PubMed] [Google Scholar]
  82. Ihle J. N. The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv Immunol. 1995;60:1–35. doi: 10.1016/s0065-2776(08)60582-9. [DOI] [PubMed] [Google Scholar]
  83. Johnson L. N., Noble M. E., Owen D. J. Active and inactive protein kinases: structural basis for regulation. Cell. 1996 Apr 19;85(2):149–158. doi: 10.1016/s0092-8674(00)81092-2. [DOI] [PubMed] [Google Scholar]
  84. Kadonaga J. T. Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell. 1998 Feb 6;92(3):307–313. doi: 10.1016/s0092-8674(00)80924-1. [DOI] [PubMed] [Google Scholar]
  85. Kalai M., Montero-Julian F. A., Grötzinger J., Fontaine V., Vandenbussche P., Deschuyteneer R., Wollmer A., Brailly H., Content J. Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction. Blood. 1997 Feb 15;89(4):1319–1333. [PubMed] [Google Scholar]
  86. Kalai M., Montero-Julian F. A., Grötzinger J., Wollmer A., Morelle D., Brochier J., Rose-John S., Heinrich P. C., Brailly H., Content J. Participation of two Ser-Ser-Phe-Tyr repeats in interleukin-6 (IL-6)-binding sites of the human IL-6 receptor. Eur J Biochem. 1996 Jun 15;238(3):714–723. doi: 10.1111/j.1432-1033.1996.0714w.x. [DOI] [PubMed] [Google Scholar]
  87. Kaptein A., Paillard V., Saunders M. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J Biol Chem. 1996 Mar 15;271(11):5961–5964. doi: 10.1074/jbc.271.11.5961. [DOI] [PubMed] [Google Scholar]
  88. Karow J., Hudson K. R., Hall M. A., Vernallis A. B., Taylor J. A., Gossler A., Heath J. K. Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor. Biochem J. 1996 Sep 1;318(Pt 2):489–495. doi: 10.1042/bj3180489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Kawata T., Shevchenko A., Fukuzawa M., Jermyn K. A., Totty N. F., Zhukovskaya N. V., Sterling A. E., Mann M., Williams J. G. SH2 signaling in a lower eukaryote: a STAT protein that regulates stalk cell differentiation in dictyostelium. Cell. 1997 Jun 13;89(6):909–916. doi: 10.1016/s0092-8674(00)80276-7. [DOI] [PubMed] [Google Scholar]
  90. Kazlauskas A., Feng G. S., Pawson T., Valius M. The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):6939–6943. doi: 10.1073/pnas.90.15.6939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Keegan K., Cooper J. A. Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, SHPTP2, with another SH2-containing protein, Grb7. Oncogene. 1996 Apr 4;12(7):1537–1544. [PubMed] [Google Scholar]
  92. Kim H., Hawley T. S., Hawley R. G., Baumann H. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Mol Cell Biol. 1998 Mar;18(3):1525–1533. doi: 10.1128/mcb.18.3.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Kim T. K., Maniatis T. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science. 1996 Sep 20;273(5282):1717–1719. doi: 10.1126/science.273.5282.1717. [DOI] [PubMed] [Google Scholar]
  94. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood. 1995 Aug 15;86(4):1243–1254. [PubMed] [Google Scholar]
  95. Klinghoffer R. A., Kazlauskas A. Identification of a putative Syp substrate, the PDGF beta receptor. J Biol Chem. 1995 Sep 22;270(38):22208–22217. doi: 10.1074/jbc.270.38.22208. [DOI] [PubMed] [Google Scholar]
  96. Kohlhuber F., Rogers N. C., Watling D., Feng J., Guschin D., Briscoe J., Witthuhn B. A., Kotenko S. V., Pestka S., Stark G. R. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol Cell Biol. 1997 Feb;17(2):695–706. doi: 10.1128/mcb.17.2.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994 Mar 24;368(6469):339–342. doi: 10.1038/368339a0. [DOI] [PubMed] [Google Scholar]
  98. Kordula T., Rydel R. E., Brigham E. F., Horn F., Heinrich P. C., Travis J. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem. 1998 Feb 13;273(7):4112–4118. doi: 10.1074/jbc.273.7.4112. [DOI] [PubMed] [Google Scholar]
  99. Korzus E., Nagase H., Rydell R., Travis J. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem. 1997 Jan 10;272(2):1188–1196. doi: 10.1074/jbc.272.2.1188. [DOI] [PubMed] [Google Scholar]
  100. Kuhné M. R., Pawson T., Lienhard G. E., Feng G. S. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem. 1993 Jun 5;268(16):11479–11481. [PubMed] [Google Scholar]
  101. Kuropatwinski K. K., De Imus C., Gearing D., Baumann H., Mosley B. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6. J Biol Chem. 1997 Jun 13;272(24):15135–15144. doi: 10.1074/jbc.272.24.15135. [DOI] [PubMed] [Google Scholar]
  102. Lai C. F., Ripperger J., Morella K. K., Wang Y., Gearing D. P., Fey G. H., Baumann H. Separate signaling mechanisms are involved in the control of STAT protein activation and gene regulation via the interleukin 6 response element by the box 3 motif of gp130. J Biol Chem. 1995 Jun 23;270(25):14847–14850. doi: 10.1074/jbc.270.25.14847. [DOI] [PubMed] [Google Scholar]
  103. Lai C. F., Ripperger J., Morella K. K., Wang Y., Gearing D. P., Horseman N. D., Campos S. P., Fey G. H., Baumann H. STAT3 and STAT5B are targets of two different signal pathways activated by hematopoietin receptors and control transcription via separate cytokine response elements. J Biol Chem. 1995 Oct 6;270(40):23254–23257. doi: 10.1074/jbc.270.40.23254. [DOI] [PubMed] [Google Scholar]
  104. Lechleider R. J., Sugimoto S., Bennett A. M., Kashishian A. S., Cooper J. A., Shoelson S. E., Walsh C. T., Neel B. G. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. J Biol Chem. 1993 Oct 15;268(29):21478–21481. [PubMed] [Google Scholar]
  105. Levy D. E. The house that Jak/Stat built. Cytokine Growth Factor Rev. 1997 Mar;8(1):81–90. doi: 10.1016/s1359-6101(96)00054-8. [DOI] [PubMed] [Google Scholar]
  106. Li W., Nishimura R., Kashishian A., Batzer A. G., Kim W. J., Cooper J. A., Schlessinger J. A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase. Mol Cell Biol. 1994 Jan;14(1):509–517. doi: 10.1128/mcb.14.1.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Look D. C., Pelletier M. R., Tidwell R. M., Roswit W. T., Holtzman M. J. Stat1 depends on transcriptional synergy with Sp1. J Biol Chem. 1995 Dec 22;270(51):30264–30267. doi: 10.1074/jbc.270.51.30264. [DOI] [PubMed] [Google Scholar]
  108. Luo H., Rose P., Barber D., Hanratty W. P., Lee S., Roberts T. M., D'Andrea A. D., Dearolf C. R. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol Cell Biol. 1997 Mar;17(3):1562–1571. doi: 10.1128/mcb.17.3.1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Lust J. A., Donovan K. A., Kline M. P., Greipp P. R., Kyle R. A., Maihle N. J. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine. 1992 Mar;4(2):96–100. doi: 10.1016/1043-4666(92)90043-q. [DOI] [PubMed] [Google Scholar]
  110. Lütticken C., Coffer P., Yuan J., Schwartz C., Caldenhoven E., Schindler C., Kruijer W., Heinrich P. C., Horn F. Interleukin-6-induced serine phosphorylation of transcription factor APRF: evidence for a role in interleukin-6 target gene induction. FEBS Lett. 1995 Feb 27;360(2):137–143. doi: 10.1016/0014-5793(95)00076-l. [DOI] [PubMed] [Google Scholar]
  111. Lütticken C., Wegenka U. M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., Harpur A. G., Wilks A. F., Yasukawa K., Taga T. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science. 1994 Jan 7;263(5143):89–92. doi: 10.1126/science.8272872. [DOI] [PubMed] [Google Scholar]
  112. Mackiewicz A., Schooltink H., Heinrich P. C., Rose-John S. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol. 1992 Sep 15;149(6):2021–2027. [PubMed] [Google Scholar]
  113. Matsuda T., Fukada T., Takahashi-Tezuka M., Okuyama Y., Fujitani Y., Hanazono Y., Hirai H., Hirano T. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J Biol Chem. 1995 May 12;270(19):11037–11039. doi: 10.1074/jbc.270.19.11037. [DOI] [PubMed] [Google Scholar]
  114. Matsuda T., Takahashi-Tezuka M., Fukada T., Okuyama Y., Fujitani Y., Tsukada S., Mano H., Hirai H., Witte O. N., Hirano T. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood. 1995 Feb 1;85(3):627–633. [PubMed] [Google Scholar]
  115. Matsuda T., Yamanaka Y., Hirano T. Interleukin-6-induced tyrosine phosphorylation of multiple proteins in murine hematopoietic lineage cells. Biochem Biophys Res Commun. 1994 Apr 29;200(2):821–828. doi: 10.1006/bbrc.1994.1525. [DOI] [PubMed] [Google Scholar]
  116. McDonald N. Q., Panayotatos N., Hendrickson W. A. Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing. EMBO J. 1995 Jun 15;14(12):2689–2699. doi: 10.1002/j.1460-2075.1995.tb07269.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Mei L., Doherty C. A., Huganir R. L. RNA splicing regulates the activity of a SH2 domain-containing protein tyrosine phosphatase. J Biol Chem. 1994 Apr 22;269(16):12254–12262. [PubMed] [Google Scholar]
  118. Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L. S., Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem. 1996 Dec 20;271(51):32635–32643. doi: 10.1074/jbc.271.51.32635. [DOI] [PubMed] [Google Scholar]
  119. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 1993 Jun 18;260(5115):1808–1810. doi: 10.1126/science.8511589. [DOI] [PubMed] [Google Scholar]
  120. Murakami M., Narazaki M., Hibi M., Yawata H., Yasukawa K., Hamaguchi M., Taga T., Kishimoto T. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11349–11353. doi: 10.1073/pnas.88.24.11349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Müllberg J., Schooltink H., Stoyan T., Günther M., Graeve L., Buse G., Mackiewicz A., Heinrich P. C., Rose-John S. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol. 1993 Feb;23(2):473–480. doi: 10.1002/eji.1830230226. [DOI] [PubMed] [Google Scholar]
  122. Müller-Newen G., Köhne C., Heinrich P. C. Soluble receptors for cytokines and growth factors. Int Arch Allergy Immunol. 1996 Oct;111(2):99–106. doi: 10.1159/000237353. [DOI] [PubMed] [Google Scholar]
  123. Müller-Newen G., Köhne C., Keul R., Hemmann U., Müller-Esterl W., Wijdenes J., Brakenhoff J. P., Hart M. H., Heinrich P. C. Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. Eur J Biochem. 1996 Mar 15;236(3):837–842. doi: 10.1111/j.1432-1033.1996.00837.x. [DOI] [PubMed] [Google Scholar]
  124. Müller M., Laxton C., Briscoe J., Schindler C., Improta T., Darnell J. E., Jr, Stark G. R., Kerr I. M. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 1993 Nov;12(11):4221–4228. doi: 10.1002/j.1460-2075.1993.tb06106.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K. Structure and function of a new STAT-induced STAT inhibitor. Nature. 1997 Jun 26;387(6636):924–929. doi: 10.1038/43219. [DOI] [PubMed] [Google Scholar]
  126. Nakamura N., Chin H., Miyasaka N., Miura O. An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of Stat5 and transduces a growth signal in hematopoietic cells. J Biol Chem. 1996 Aug 9;271(32):19483–19488. doi: 10.1074/jbc.271.32.19483. [DOI] [PubMed] [Google Scholar]
  127. Nandurkar H. H., Robb L., Tarlinton D., Barnett L., Köntgen F., Begley C. G. Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis. Blood. 1997 Sep 15;90(6):2148–2159. [PubMed] [Google Scholar]
  128. Narazaki M., Witthuhn B. A., Yoshida K., Silvennoinen O., Yasukawa K., Ihle J. N., Kishimoto T., Taga T. Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2285–2289. doi: 10.1073/pnas.91.6.2285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Narazaki M., Yasukawa K., Saito T., Ohsugi Y., Fukui H., Koishihara Y., Yancopoulos G. D., Taga T., Kishimoto T. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood. 1993 Aug 15;82(4):1120–1126. [PubMed] [Google Scholar]
  130. Neddermann P., Graziani R., Ciliberto G., Paonessa G. Functional expression of soluble human interleukin-11 (IL-11) receptor alpha and stoichiometry of in vitro IL-11 receptor complexes with gp130. J Biol Chem. 1996 Nov 29;271(48):30986–30991. doi: 10.1074/jbc.271.48.30986. [DOI] [PubMed] [Google Scholar]
  131. Nesbitt J. E., Fuller G. M. Dynamics of interleukin-6 internalization and degradation in rat hepatocytes. J Biol Chem. 1992 Mar 25;267(9):5739–5742. [PubMed] [Google Scholar]
  132. Neubauer H., Cumano A., Müller M., Wu H., Huffstadt U., Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 1998 May 1;93(3):397–409. doi: 10.1016/s0092-8674(00)81168-x. [DOI] [PubMed] [Google Scholar]
  133. Ng J., Cantrell D. STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J Biol Chem. 1997 Sep 26;272(39):24542–24549. doi: 10.1074/jbc.272.39.24542. [DOI] [PubMed] [Google Scholar]
  134. Novak U., Mui A., Miyajima A., Paradiso L. Formation of STAT5-containing DNA binding complexes in response to colony-stimulating factor-1 and platelet-derived growth factor. J Biol Chem. 1996 Aug 2;271(31):18350–18354. doi: 10.1074/jbc.271.31.18350. [DOI] [PubMed] [Google Scholar]
  135. Novak U., Nice E., Hamilton J. A., Paradiso L. Requirement for Y706 of the murine (or Y708 of the human) CSF-1 receptor for STAT1 activation in response to CSF-1. Oncogene. 1996 Dec 19;13(12):2607–2613. [PubMed] [Google Scholar]
  136. O'Brien C. A., Manolagas S. C. Isolation and characterization of the human gp130 promoter. Regulation by STATS. J Biol Chem. 1997 Jun 6;272(23):15003–15010. doi: 10.1074/jbc.272.23.15003. [DOI] [PubMed] [Google Scholar]
  137. Ohno H., Stewart J., Fournier M. C., Bosshart H., Rhee I., Miyatake S., Saito T., Gallusser A., Kirchhausen T., Bonifacino J. S. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science. 1995 Sep 29;269(5232):1872–1875. doi: 10.1126/science.7569928. [DOI] [PubMed] [Google Scholar]
  138. Owczarek C. M., Zhang Y., Layton M. J., Metcalf D., Roberts B., Nicola N. A. The unusual species cross-reactivity of the leukemia inhibitory factor receptor alpha-chain is determined primarily by the immunoglobulin-like domain. J Biol Chem. 1997 Sep 19;272(38):23976–23985. doi: 10.1074/jbc.272.38.23976. [DOI] [PubMed] [Google Scholar]
  139. Paonessa G., Graziani R., De Serio A., Savino R., Ciapponi L., Lahm A., Salvati A. L., Toniatti C., Ciliberto G. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J. 1995 May 1;14(9):1942–1951. doi: 10.1002/j.1460-2075.1995.tb07186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Parganas E., Wang D., Stravopodis D., Topham D. J., Marine J. C., Teglund S., Vanin E. F., Bodner S., Colamonici O. R., van Deursen J. M. Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 1998 May 1;93(3):385–395. doi: 10.1016/s0092-8674(00)81167-8. [DOI] [PubMed] [Google Scholar]
  141. Park O. K., Schaefer T. S., Nathans D. In vitro activation of Stat3 by epidermal growth factor receptor kinase. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13704–13708. doi: 10.1073/pnas.93.24.13704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Pellegrini S., Dusanter-Fourt I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur J Biochem. 1997 Sep 15;248(3):615–633. doi: 10.1111/j.1432-1033.1997.00615.x. [DOI] [PubMed] [Google Scholar]
  143. Peng Z. Y., Cartwright C. A. Regulation of the Src tyrosine kinase and Syp tyrosine phosphatase by their cellular association. Oncogene. 1995 Nov 16;11(10):1955–1962. [PubMed] [Google Scholar]
  144. Pennica D., King K. L., Shaw K. J., Luis E., Rullamas J., Luoh S. M., Darbonne W. C., Knutzon D. S., Yen R., Chien K. R. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1142–1146. doi: 10.1073/pnas.92.4.1142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Perkins L. A., Larsen I., Perrimon N. corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell. 1992 Jul 24;70(2):225–236. doi: 10.1016/0092-8674(92)90098-w. [DOI] [PubMed] [Google Scholar]
  146. Picard D., Yamamoto K. R. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 1987 Nov;6(11):3333–3340. doi: 10.1002/j.1460-2075.1987.tb02654.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Pluskey S., Wandless T. J., Walsh C. T., Shoelson S. E. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J Biol Chem. 1995 Feb 17;270(7):2897–2900. doi: 10.1074/jbc.270.7.2897. [DOI] [PubMed] [Google Scholar]
  148. Quelle F. W., Sato N., Witthuhn B. A., Inhorn R. C., Eder M., Miyajima A., Griffin J. D., Ihle J. N. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol. 1994 Jul;14(7):4335–4341. doi: 10.1128/mcb.14.7.4335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Ray D. W., Ren S. G., Melmed S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest. 1996 Apr 15;97(8):1852–1859. doi: 10.1172/JCI118615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Robb L., Li R., Hartley L., Nandurkar H. H., Koentgen F., Begley C. G. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med. 1998 Mar;4(3):303–308. doi: 10.1038/nm0398-303. [DOI] [PubMed] [Google Scholar]
  151. Robinson R. C., Grey L. M., Staunton D., Vankelecom H., Vernallis A. B., Moreau J. F., Stuart D. I., Heath J. K., Jones E. Y. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell. 1994 Jul 1;77(7):1101–1116. doi: 10.1016/0092-8674(94)90449-9. [DOI] [PubMed] [Google Scholar]
  152. Robledo O., Fourcin M., Chevalier S., Guillet C., Auguste P., Pouplard-Barthelaix A., Pennica D., Gascan H. Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component. J Biol Chem. 1997 Feb 21;272(8):4855–4863. doi: 10.1074/jbc.272.8.4855. [DOI] [PubMed] [Google Scholar]
  153. Rodig S. J., Meraz M. A., White J. M., Lampe P. A., Riley J. K., Arthur C. D., King K. L., Sheehan K. C., Yin L., Pennica D. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell. 1998 May 1;93(3):373–383. doi: 10.1016/s0092-8674(00)81166-6. [DOI] [PubMed] [Google Scholar]
  154. Rose-John S., Heinrich P. C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J. 1994 Jun 1;300(Pt 2):281–290. doi: 10.1042/bj3000281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Rui L., Mathews L. S., Hotta K., Gustafson T. A., Carter-Su C. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol Cell Biol. 1997 Nov;17(11):6633–6644. doi: 10.1128/mcb.17.11.6633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Sakai I., Nabell L., Kraft A. S. Signal transduction by a CD16/CD7/Jak2 fusion protein. J Biol Chem. 1995 Aug 4;270(31):18420–18427. doi: 10.1074/jbc.270.31.18420. [DOI] [PubMed] [Google Scholar]
  157. Sasse J., Hemmann U., Schwartz C., Schniertshauer U., Heesel B., Landgraf C., Schneider-Mergener J., Heinrich P. C., Horn F. Mutational analysis of acute-phase response factor/Stat3 activation and dimerization. Mol Cell Biol. 1997 Aug;17(8):4677–4686. doi: 10.1128/mcb.17.8.4677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Schaefer T. S., Sanders L. K., Nathans D. Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9097–9101. doi: 10.1073/pnas.92.20.9097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Schaper F., Siewert E., Gómez-Lechon M. J., Gatsios P., Sachs M., Birchmeier W., Heinrich P. C., Castell J. Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes. FEBS Lett. 1997 Mar 17;405(1):99–103. doi: 10.1016/s0014-5793(97)00167-1. [DOI] [PubMed] [Google Scholar]
  160. Schiemann W. P., Bartoe J. L., Nathanson N. M. Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha- and gp130-mediated stimulation of mitogen-activated protein kinase. Evidence for participation of multiple signaling pathways which converge at Ras. J Biol Chem. 1997 Jun 27;272(26):16631–16636. doi: 10.1074/jbc.272.26.16631. [DOI] [PubMed] [Google Scholar]
  161. Schindler C., Fu X. Y., Improta T., Aebersold R., Darnell J. E., Jr Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7836–7839. doi: 10.1073/pnas.89.16.7836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Schindler U., Wu P., Rothe M., Brasseur M., McKnight S. L. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity. 1995 Jun;2(6):689–697. doi: 10.1016/1074-7613(95)90013-6. [DOI] [PubMed] [Google Scholar]
  163. Schumann R. R., Kirschning C. J., Unbehaun A., Aberle H. P., Knope H. P., Lamping N., Ulevitch R. J., Herrmann F. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol. 1996 Jul;16(7):3490–3503. doi: 10.1128/mcb.16.7.3490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Seidel H. M., Milocco L. H., Lamb P., Darnell J. E., Jr, Stein R. B., Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3041–3045. doi: 10.1073/pnas.92.7.3041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Sekimoto T., Imamoto N., Nakajima K., Hirano T., Yoneda Y. Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1. EMBO J. 1997 Dec 1;16(23):7067–7077. doi: 10.1093/emboj/16.23.7067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Sekimoto T., Nakajima K., Tachibana T., Hirano T., Yoneda Y. Interferon-gamma-dependent nuclear import of Stat1 is mediated by the GTPase activity of Ran/TC4. J Biol Chem. 1996 Dec 6;271(49):31017–31020. doi: 10.1074/jbc.271.49.31017. [DOI] [PubMed] [Google Scholar]
  167. Shuai K., Horvath C. M., Huang L. H., Qureshi S. A., Cowburn D., Darnell J. E., Jr Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell. 1994 Mar 11;76(5):821–828. doi: 10.1016/0092-8674(94)90357-3. [DOI] [PubMed] [Google Scholar]
  168. Shuai K., Stark G. R., Kerr I. M., Darnell J. E., Jr A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science. 1993 Sep 24;261(5129):1744–1746. doi: 10.1126/science.7690989. [DOI] [PubMed] [Google Scholar]
  169. Simpson R. J., Hammacher A., Smith D. K., Matthews J. M., Ward L. D. Interleukin-6: structure-function relationships. Protein Sci. 1997 May;6(5):929–955. doi: 10.1002/pro.5560060501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Somers W., Stahl M., Seehra J. S. 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J. 1997 Mar 3;16(5):989–997. doi: 10.1093/emboj/16.5.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Sonne O., Davidsen O., Møller B. K., Munck Petersen C. Cellular targets and receptors for interleukin-6. I. In vivo and in vitro uptake of IL-6 in liver and hepatocytes. Eur J Clin Invest. 1990 Aug;20(4):366–376. doi: 10.1111/j.1365-2362.1990.tb01872.x. [DOI] [PubMed] [Google Scholar]
  172. Stahl N., Boulton T. G., Farruggella T., Ip N. Y., Davis S., Witthuhn B. A., Quelle F. W., Silvennoinen O., Barbieri G., Pellegrini S. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science. 1994 Jan 7;263(5143):92–95. doi: 10.1126/science.8272873. [DOI] [PubMed] [Google Scholar]
  173. Stahl N., Farruggella T. J., Boulton T. G., Zhong Z., Darnell J. E., Jr, Yancopoulos G. D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science. 1995 Mar 3;267(5202):1349–1353. doi: 10.1126/science.7871433. [DOI] [PubMed] [Google Scholar]
  174. Stancato L. F., David M., Carter-Su C., Larner A. C., Pratt W. B. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. J Biol Chem. 1996 Feb 23;271(8):4134–4137. doi: 10.1074/jbc.271.8.4134. [DOI] [PubMed] [Google Scholar]
  175. Starr R., Willson T. A., Viney E. M., Murray L. J., Rayner J. R., Jenkins B. J., Gonda T. J., Alexander W. S., Metcalf D., Nicola N. A. A family of cytokine-inducible inhibitors of signalling. Nature. 1997 Jun 26;387(6636):917–921. doi: 10.1038/43206. [DOI] [PubMed] [Google Scholar]
  176. Stein-Gerlach M., Kharitonenkov A., Vogel W., Ali S., Ullrich A. Protein-tyrosine phosphatase 1D modulates its own state of tyrosine phosphorylation. J Biol Chem. 1995 Oct 20;270(42):24635–24637. doi: 10.1074/jbc.270.42.24635. [DOI] [PubMed] [Google Scholar]
  177. Stephanou A., Isenberg D. A., Akira S., Kishimoto T., Latchman D. S. The nuclear factor interleukin-6 (NF-IL6) and signal transducer and activator of transcription-3 (STAT-3) signalling pathways co-operate to mediate the activation of the hsp90beta gene by interleukin-6 but have opposite effects on its inducibility by heat shock. Biochem J. 1998 Feb 15;330(Pt 1):189–195. doi: 10.1042/bj3300189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Stewart C. L., Kaspar P., Brunet L. J., Bhatt H., Gadi I., Köntgen F., Abbondanzo S. J. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 1992 Sep 3;359(6390):76–79. doi: 10.1038/359076a0. [DOI] [PubMed] [Google Scholar]
  179. Stöcklin E., Wissler M., Gouilleux F., Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature. 1996 Oct 24;383(6602):726–728. doi: 10.1038/383726a0. [DOI] [PubMed] [Google Scholar]
  180. Symes A., Gearan T., Eby J., Fink J. S. Integration of Jak-Stat and AP-1 signaling pathways at the vasoactive intestinal peptide cytokine response element regulates ciliary neurotrophic factor-dependent transcription. J Biol Chem. 1997 Apr 11;272(15):9648–9654. doi: 10.1074/jbc.272.15.9648. [DOI] [PubMed] [Google Scholar]
  181. Symes A., Stahl N., Reeves S. A., Farruggella T., Servidei T., Gearan T., Yancopoulos G., Fink J. S. The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression. Curr Biol. 1997 Sep 1;7(9):697–700. doi: 10.1016/s0960-9822(06)00298-3. [DOI] [PubMed] [Google Scholar]
  182. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 1989 Aug 11;58(3):573–581. doi: 10.1016/0092-8674(89)90438-8. [DOI] [PubMed] [Google Scholar]
  183. Takahashi-Tezuka M., Hibi M., Fujitani Y., Fukada T., Yamaguchi T., Hirano T. Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. Oncogene. 1997 May 15;14(19):2273–2282. doi: 10.1038/sj.onc.1201071. [DOI] [PubMed] [Google Scholar]
  184. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3801–3804. doi: 10.1073/pnas.94.8.3801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Takeshita T., Arita T., Higuchi M., Asao H., Endo K., Kuroda H., Tanaka N., Murata K., Ishii N., Sugamura K. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity. 1997 Apr;6(4):449–457. doi: 10.1016/s1074-7613(00)80288-5. [DOI] [PubMed] [Google Scholar]
  186. Tanigawa T., Nicola N., McArthur G. A., Strasser A., Begley C. G. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor. Blood. 1995 Jan 15;85(2):379–390. [PubMed] [Google Scholar]
  187. Tanner J. W., Chen W., Young R. L., Longmore G. D., Shaw A. S. The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J Biol Chem. 1995 Mar 24;270(12):6523–6530. doi: 10.1074/jbc.270.12.6523. [DOI] [PubMed] [Google Scholar]
  188. Tauchi T., Feng G. S., Shen R., Song H. Y., Donner D., Pawson T., Broxmeyer H. E. SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase. J Biol Chem. 1994 May 27;269(21):15381–15387. [PubMed] [Google Scholar]
  189. Thiel S., Behrmann I., Dittrich E., Muys L., Tavernier J., Wijdenes J., Heinrich P. C., Graeve L. Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway. Biochem J. 1998 Feb 15;330(Pt 1):47–54. doi: 10.1042/bj3300047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Trowbridge I. S., Collawn J. F., Hopkins C. R. Signal-dependent membrane protein trafficking in the endocytic pathway. Annu Rev Cell Biol. 1993;9:129–161. doi: 10.1146/annurev.cb.09.110193.001021. [DOI] [PubMed] [Google Scholar]
  191. Velazquez L., Mogensen K. E., Barbieri G., Fellous M., Uzé G., Pellegrini S. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction. J Biol Chem. 1995 Feb 17;270(7):3327–3334. doi: 10.1074/jbc.270.7.3327. [DOI] [PubMed] [Google Scholar]
  192. Vinkemeier U., Cohen S. L., Moarefi I., Chait B. T., Kuriyan J., Darnell J. E., Jr DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 1996 Oct 15;15(20):5616–5626. [PMC free article] [PubMed] [Google Scholar]
  193. Vinkemeier U., Moarefi I., Darnell J. E., Jr, Kuriyan J. Structure of the amino-terminal protein interaction domain of STAT-4. Science. 1998 Feb 13;279(5353):1048–1052. doi: 10.1126/science.279.5353.1048. [DOI] [PubMed] [Google Scholar]
  194. Vogel W., Lammers R., Huang J., Ullrich A. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science. 1993 Mar 12;259(5101):1611–1614. doi: 10.1126/science.7681217. [DOI] [PubMed] [Google Scholar]
  195. Wang D., Stravopodis D., Teglund S., Kitazawa J., Ihle J. N. Naturally occurring dominant negative variants of Stat5. Mol Cell Biol. 1996 Nov;16(11):6141–6148. doi: 10.1128/mcb.16.11.6141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Wang Y., Fuller G. M. Phosphorylation and internalization of gp130 occur after IL-6 activation of Jak2 kinase in hepatocytes. Mol Biol Cell. 1994 Jul;5(7):819–828. doi: 10.1091/mbc.5.7.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Ward L. D., Howlett G. J., Discolo G., Yasukawa K., Hammacher A., Moritz R. L., Simpson R. J. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J Biol Chem. 1994 Sep 16;269(37):23286–23289. [PubMed] [Google Scholar]
  198. Wegenka U. M., Buschmann J., Lütticken C., Heinrich P. C., Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol. 1993 Jan;13(1):276–288. doi: 10.1128/mcb.13.1.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Wen Z., Darnell J. E., Jr Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 1997 Jun 1;25(11):2062–2067. doi: 10.1093/nar/25.11.2062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Wen Z., Zhong Z., Darnell J. E., Jr Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 1995 Jul 28;82(2):241–250. doi: 10.1016/0092-8674(95)90311-9. [DOI] [PubMed] [Google Scholar]
  201. Wong L., Johnson G. R. Epidermal growth factor induces coupling of protein-tyrosine phosphatase 1D to GRB2 via the COOH-terminal SH3 domain of GRB2. J Biol Chem. 1996 Aug 30;271(35):20981–20984. doi: 10.1074/jbc.271.35.20981. [DOI] [PubMed] [Google Scholar]
  202. Xia K., Mukhopadhyay N. K., Inhorn R. C., Barber D. L., Rose P. E., Lee R. S., Narsimhan R. P., D'Andrea A. D., Griffin J. D., Roberts T. M. The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11681–11686. doi: 10.1073/pnas.93.21.11681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Xu G. Y., Yu H. A., Hong J., Stahl M., McDonagh T., Kay L. E., Cumming D. A. Solution structure of recombinant human interleukin-6. J Mol Biol. 1997 May 2;268(2):468–481. doi: 10.1006/jmbi.1997.0933. [DOI] [PubMed] [Google Scholar]
  204. Xu X., Sun Y. L., Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science. 1996 Aug 9;273(5276):794–797. doi: 10.1126/science.273.5276.794. [DOI] [PubMed] [Google Scholar]
  205. Yamada T., Tobita K., Osada S., Nishihara T., Imagawa M. CCAAT/enhancer-binding protein delta gene expression is mediated by APRF/STAT3. J Biochem. 1997 Apr;121(4):731–738. doi: 10.1093/oxfordjournals.jbchem.a021647. [DOI] [PubMed] [Google Scholar]
  206. Yamamoto H., Crow M., Cheng L., Lakatta E., Kinsella J. PDGF receptor-to-nucleus signaling of p91 (STAT1 alpha) transcription factor in rat smooth muscle cells. Exp Cell Res. 1996 Jan 10;222(1):125–130. doi: 10.1006/excr.1996.0016. [DOI] [PubMed] [Google Scholar]
  207. Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science. 1988 Aug 12;241(4867):825–828. doi: 10.1126/science.3136546. [DOI] [PubMed] [Google Scholar]
  208. Yan H., Piazza F., Krishnan K., Pine R., Krolewski J. J. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase. J Biol Chem. 1998 Feb 13;273(7):4046–4051. doi: 10.1074/jbc.273.7.4046. [DOI] [PubMed] [Google Scholar]
  209. Yan R., Small S., Desplan C., Dearolf C. R., Darnell J. E., Jr Identification of a Stat gene that functions in Drosophila development. Cell. 1996 Feb 9;84(3):421–430. doi: 10.1016/s0092-8674(00)81287-8. [DOI] [PubMed] [Google Scholar]
  210. Yawata H., Yasukawa K., Natsuka S., Murakami M., Yamasaki K., Hibi M., Taga T., Kishimoto T. Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J. 1993 Apr;12(4):1705–1712. doi: 10.1002/j.1460-2075.1993.tb05815.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Yetter A., Uddin S., Krolewski J. J., Jiao H., Yi T., Platanias L. C. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem. 1995 Aug 4;270(31):18179–18182. doi: 10.1074/jbc.270.31.18179. [DOI] [PubMed] [Google Scholar]
  212. Yin T., Shen R., Feng G. S., Yang Y. C. Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J Biol Chem. 1997 Jan 10;272(2):1032–1037. doi: 10.1074/jbc.272.2.1032. [DOI] [PubMed] [Google Scholar]
  213. Yin T., Taga T., Tsang M. L., Yasukawa K., Kishimoto T., Yang Y. C. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J Immunol. 1993 Sep 1;151(5):2555–2561. [PubMed] [Google Scholar]
  214. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):407–411. doi: 10.1073/pnas.93.1.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Zhang D., Sun M., Samols D., Kushner I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem. 1996 Apr 19;271(16):9503–9509. doi: 10.1074/jbc.271.16.9503. [DOI] [PubMed] [Google Scholar]
  216. Zhang J. J., Vinkemeier U., Gu W., Chakravarti D., Horvath C. M., Darnell J. E., Jr Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15092–15096. doi: 10.1073/pnas.93.26.15092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Zhang X., Blenis J., Li H. C., Schindler C., Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science. 1995 Mar 31;267(5206):1990–1994. doi: 10.1126/science.7701321. [DOI] [PubMed] [Google Scholar]
  218. Zhang Z., Jones S., Hagood J. S., Fuentes N. L., Fuller G. M. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem. 1997 Dec 5;272(49):30607–30610. doi: 10.1074/jbc.272.49.30607. [DOI] [PubMed] [Google Scholar]
  219. Zhao Y., Wagner F., Frank S. J., Kraft A. S. The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain. J Biol Chem. 1995 Jun 9;270(23):13814–13818. doi: 10.1074/jbc.270.23.13814. [DOI] [PubMed] [Google Scholar]
  220. Zhong Z., Wen Z., Darnell J. E., Jr Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4806–4810. doi: 10.1073/pnas.91.11.4806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. Zohlnhöfer D., Graeve L., Rose-John S., Schooltink H., Dittrich E., Heinrich P. C. The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand. FEBS Lett. 1992 Jul 20;306(2-3):219–222. doi: 10.1016/0014-5793(92)81004-6. [DOI] [PubMed] [Google Scholar]
  222. de Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 1992 Jan 17;255(5042):306–312. doi: 10.1126/science.1549776. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES